Colchicine: an ancient drug with novel applications.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28832953.
- Also identified by DOI 10.1111/bjd.15896 and PMC identifier 5812812.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Colchicine is a treatment for gout that has been used for more than a millennium. It is the treatment of choice for familial Mediterranean fever and its associated complication, amyloidosis. The 2009 U.S. Food and Drug Administration approval of colchicine as a new drug had research consequences. Recent investigations with large cohorts of patients with gout who have been taking colchicine for years have demonstrated novel applications within oncology, immunology, cardiology and dermatology. Some emerging dermatological uses include the treatment of epidermolysis bullosa acquisita, leucocytoclastic vasculitis, aphthous stomatitis and others. In this work we relate the history and the new horizon of this ancient medicine.
Medical subject headings
- Colchicine
- Dermatologic Agents
- Gout Suppressants
- Tubulin Modulators